#373 Recap Extravaganza 2022
The Curbsiders Internal Medicine Podcast
00:00
Is There a Chronic Disease State?
The new fancy GIP slash GOP one agonist, Terzepitide, which is probably going to be approved at some point. It's not yet FDA approved for for obesity but it's there. There's a fast track application. Oh, and probably sometime in 2023, the second surmount trial is going to finish. And they're expecting that that will have enough data for them to get it approved for Obesity.
Transcript
Play full episode
